![Megan Filoon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Megan Filoon
Responsabile della Conformità presso
ELICIO THERAPEUTICS, INC.
Profilo
Ms. Megan Filoon is a Secretary, Compliance Officer & General Counsel at Elicio Therapeutics, Inc. Ms. Filoon was previously employed as a Secretary & General Counsel by Molecular Templates, Inc. and a Corporate Associate by Blank Rome LLP.
She received her undergraduate degree from Boston University and a graduate degree from Rutgers Law School.
Posizioni attive di Megan Filoon
| Società | Posizione | Inizio |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Responsabile della Conformità | 28/08/2023 |
Precedenti posizioni note di Megan Filoon
| Società | Posizione | Fine |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Consigliere Generale | 01/08/2023 |
Blank Rome LLP
 Blank Rome LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2018 |
Formazione di Megan Filoon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
46
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blank Rome LLP
Blank Rome LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Rutgers Law School
 Rutgers Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Elicio Therapeutics, Inc.
 Elicio Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapies | Health Technology |
